These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 212186)

  • 1. Antagonistic action between cyclic adenosine 3':5'-monophosphate and estrogen in rat mammary tumor growth control.
    Cho-Chung YS
    Cancer Res; 1978 Nov; 38(11 Pt 2):4071-5. PubMed ID: 212186
    [No Abstract]   [Full Text] [Related]  

  • 2. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
    Bodwin JS; Clair T; Cho-Chung YS
    Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear protein phosphorylation and hormone-dependent mammary tumor regression following dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
    Cho-Chung YS; Redler BH; Lewallen RP
    Cancer Res; 1978 Oct; 38(10):3405-9. PubMed ID: 210937
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory interrelationships for insulin and estrogen action in mammary tumors.
    Hilf R; Hissin PJ; Shafie SM
    Cancer Res; 1978 Nov; 38(11 Pt 2):4076-85. PubMed ID: 100214
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic AMP and mammary tumor regression.
    Cho-Chung YS
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(4):395-403. PubMed ID: 6254654
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic adenosine 3',5'-monophosphate-binding protein: role in ovariectomy-induced regression of a hormone-dependent mammary tumor in Sprague-Dawley female rats.
    Cho-Chung YS; Bodwin JS; Clair T
    J Natl Cancer Inst; 1978 May; 60(5):1175-8. PubMed ID: 205664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events.
    Bodwin JS; Hirayama PH; Rego JA; Cho-Chung YS
    J Natl Cancer Inst; 1981 Feb; 66(2):321-6. PubMed ID: 6256577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic action between cyclic AMP and estrogen in phosphorylation of mammary tumor nuclear proteins.
    Cho-chung YS; Doud FJ
    Cancer Lett; 1978 Oct; 5(4):219-24. PubMed ID: 210929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic adenosine 3':5-monophosphate receptor proteins in hormone-dependent and -independent rat mammary tumors.
    Cho-Chung YS; Clair T; Schwimmer M; Steinberg L; Rego J; Grantham F
    Cancer Res; 1981 May; 41(5):1840-6. PubMed ID: 7214351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptors in androgen-induced breast tumor regression.
    Zava DT; McGuire WL
    Cancer Res; 1977 Jun; 37(6):1608-10. PubMed ID: 192456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiestrogen modulation of the growth and properties of ovarian-autonomous and ovarian-dependent mammary tumors in rats.
    Tsai TL; Rutledge S; Katzenellenbogen BS
    Cancer Res; 1979 Dec; 39(12):5043-50. PubMed ID: 227594
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of hormone dependency to estrogen receptor and adenosine 3',5'-cyclic monophosphate-binding proteins in rat mammary tumors.
    Bodwin JS; Clair T; Cho-Chung YS
    J Natl Cancer Inst; 1980 Feb; 64(2):395-8. PubMed ID: 6928231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and estrogen stimulation of cytoplasmic progesterone receptor in the ovarian-dependent MXT-3590 mammary tumor line.
    Watson CS; Medina D; Clark JH
    Cancer Res; 1979 Oct; 39(10):4098-104. PubMed ID: 476646
    [No Abstract]   [Full Text] [Related]  

  • 14. The biochemical mechanisms of the stimulating action of estradiol on the growth of mammary tumours.
    Morozova TM; Mitina RL; Nagibneva IN; Ozhogina ZB; Salganik RI
    Exp Clin Endocrinol; 1986 Dec; 88(3):293-302. PubMed ID: 3030784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of cyclic nucleotides in autotransplanted 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors during their growth and regression.
    Lee C
    J Natl Cancer Inst; 1980 Nov; 65(5):1029-32. PubMed ID: 6253705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothesis. Cyclic AMP and its receptor protein in tumor growth regulation in vivo.
    Cho-Chung YS
    J Cyclic Nucleotide Res; 1980; 6(3):163-77. PubMed ID: 6255017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of cyclic AMP-mediated growth arrest of solid tumors.
    Cho-Chung YS
    Adv Cyclic Nucleotide Res; 1980; 12():111-21. PubMed ID: 6250346
    [No Abstract]   [Full Text] [Related]  

  • 18. Dibutyryl cyclic AMP mimics ovariectomy: nuclear protein phosphorylation in mammary tumor regression.
    Cho-Chung YS; Redler BH
    Science; 1977 Jul; 197(4300):272-5. PubMed ID: 195337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological significance of estradiol receptor binding to DNA.
    Khan S; Feldman M; Hollander VP
    Cancer Res; 1980 Apr; 40(4):1050-3. PubMed ID: 7357535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors.
    Turcot-Lemay L; Kelly PA
    Cancer Res; 1980 Sep; 40(9):3232-40. PubMed ID: 6253058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.